This proposed rule focuses primarily on PMTA review treatments and written content prerequisites, significantly with respect to software acceptance and filing. An software may meet up with the acceptance and filing prerequisites, but nevertheless lack important info that FDA wants to find out no matter whether it must challenge a internet marketing